Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02128659 · ClinicalTrials.gov registry record · NA

Sexual Health Empowerment for Cervical Health Literacy and Cancer Prevention

A NA study of Cervical Cancer, sponsored by Megha Ramaswamy, PhD, MPH.

Completed
Registry status
NA
Development phase
261
Enrollment target
3
Study locations

NCT02128659 is a NA study of Cervical Cancer that has completed, run by Megha Ramaswamy, PhD, MPH. The registered enrollment target is 261 participants, below the 569-participant average among 144 other Cervical Cancer trials with a reported enrollment target (54% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02128659, a NA study of Cervical Cancer, has completed, sponsored by Megha Ramaswamy, PhD, MPH.

COMPLETED
Registry status
NA
Development phase
261 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to learn if a cervical health literacy program is a practical and helpful way of improving women's cervical health knowledge and improving cancer screening behaviors, and ultimately preventing cervical cancer.

Conditions Studied

Interventions

  • BEHAVIORAL SHE Project

Study Locations (3)

Kansas

  • Wyandotte County Detention Center - Kansas City
  • University of Kansas Medical Center - Kansas City

Missouri

  • Jackson County Detention/Regional Correctional Center - Kansas City

Trial Details

FieldValue
Enrollment Target 261 participants
Start Date 2014-04
Est. Completion 2019-05-31
Phase NA

Sponsor

Megha Ramaswamy, PhD, MPH

1 total trials

What the Registry Record Tells You About NCT02128659

The ClinicalTrials.gov registry entry for NCT02128659 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 261 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 569-participant average among 144 other Cervical Cancer trials with a reported enrollment target (54% lower). The listed sponsor is Megha Ramaswamy, PhD, MPH, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 1 intervention - of which SHE Project is the first listed.

NCT02128659 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Kansas, Missouri.

Frequently Asked Questions

What is clinical trial NCT02128659 about?

NCT02128659 is a clinical study titled "Sexual Health Empowerment for Cervical Health Literacy and Cancer Prevention". The purpose of this study is to learn if a cervical health literacy program is a practical and helpful way of improving women's cervical health knowledge and improving cancer screening behaviors, and ultimately preventing cervical cancer.

What is the current status of trial NCT02128659?

This trial is currently completed. It is a NA study. The enrollment target is 261 participants. The study started on 2014-04. Estimated completion is 2019-05-31.

What conditions does trial NCT02128659 study?

This clinical trial studies the following conditions: Cervical Cancer.

What interventions are being tested in trial NCT02128659?

The interventions under investigation include: SHE Project (BEHAVIORAL).

Who is sponsoring clinical trial NCT02128659?

This trial is sponsored by Megha Ramaswamy, PhD, MPH, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02128659 being conducted?

This trial has 3 study locations across Kansas, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.